Explain this page
Arphra AIPlain-English read on The Ensign Group, Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +17.82% | +17.12% | +15.84% | +15.67% | +15.81% | +16.13% | +15.47% | +15.94% |
| Operating margin | +9.91% | +9.81% | +6.85% | +8.41% | +8.41% | +7.70% | +8.02% | +7.86% |
| EBITDA margin | +12.21% | +11.91% | +9.47% | +11.23% | +11.23% | +10.92% | +10.91% | +10.68% |
| EBIT margin | +10.08% | +9.85% | +7.53% | +9.26% | +9.17% | +8.86% | +8.52% | +8.49% |
| Pre-tax margin | +9.82% | +9.56% | +7.31% | +9.06% | +9.01% | +8.61% | +8.25% | +8.64% |
| Net margin | +7.41% | +7.43% | +5.61% | +6.99% | +6.80% | +6.65% | +6.61% | +6.36% |
| Cost structure | ||||||||
| Cost of revenue / sales | +82.18% | +82.88% | +84.16% | +84.33% | +84.19% | +85.69% | +84.87% | +82.18% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +5.78% | +5.25% | +7.05% | +5.28% | +5.33% | +6.05% | +5.74% | +5.95% |
| Effective tax rate | +23.36% | +22.29% | +23.06% | +22.70% | +24.44% | +22.38% | +24.58% | +22.61% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | +19.05% | +17.99% | +13.98% | +16.19% | +15.39% | +15.59% | +15.68% | +14.54% |
| Return on assets (ROA) | +6.83% | +6.51% | +5.01% | +6.38% | +6.30% | +6.06% | +6.13% | +5.87% |
| Return on capital (ROC) | +11.39% | +10.52% | +7.58% | +9.39% | +6.66% | +7.55% | +7.77% | +7.70% |
| Return on invested capital (ROIC) | +8.51% | +7.96% | +6.22% | +7.81% | +5.38% | +6.53% | +6.40% | +6.23% |
| Asset turnover | +92.17% | +87.64% | +89.27% | +91.24% | +92.58% | +91.08% | +92.79% | +92.35% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +7.41% | +7.43% | +5.61% | +6.99% | +6.80% | +6.65% | +6.61% | +6.36% |
| Asset turnover (× revenue / assets) | +92.17% | +87.64% | +89.27% | +91.24% | +92.58% | +91.08% | +92.79% | +92.35% |
| Equity multiplier (× assets / equity) | +279.00% | +276.43% | +279.00% | +253.71% | +244.45% | +257.26% | +255.67% | +247.51% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 0.92 | 0.88 | 0.89 | 0.91 | 0.93 | 0.91 | 0.93 | 0.92 |
| Fixed-asset turnover | 1.30 | 1.24 | 1.31 | 1.35 | 1.33 | — | — | — |
| Inventory turnover | — | — | — | — | — | — | — | — |
| Receivables turnover | 7.99 | 7.41 | 7.69 | 7.48 | 7.94 | — | — | — |
| Payables turnover | 37.15 | 32.53 | 33.82 | 36.31 | 43.75 | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 45.67 | 49.27 | 47.47 | 48.82 | 45.97 | — | — | — |
| Days inventory outstanding (DIO) | — | — | — | — | — | — | — | — |
| Days payables outstanding (DPO) | 9.82 | 11.22 | 10.79 | 10.05 | 8.34 | — | — | — |
| Cash conversion cycle | 35.84 | 38.05 | 36.68 | 38.77 | 37.63 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.42 | 1.21 | 1.80 | 1.17 | 1.64 | 1.43 | 1.46 | 1.55 |
| FCF / Net income | 1.06 | 0.82 | 1.29 | 0.63 | 1.08 | 0.95 | 0.96 | 1.02 |
| FCF margin | +7.85% | +6.11% | +7.25% | +4.43% | +7.33% | +6.29% | +6.33% | +6.46% |
| OCF margin | +10.49% | +9.01% | +10.10% | +8.15% | +11.16% | +9.53% | +9.64% | +9.83% |
| CapEx / Revenue | +2.65% | +2.89% | +2.85% | +3.71% | +3.83% | +3.54% | +3.38% | +3.56% |
| CapEx / D&A | 1.24 | 1.40 | 1.47 | 1.88 | 1.86 | — | — | — |
| Stock-based comp / Revenue | +0.71% | +0.75% | +0.82% | +0.85% | +0.95% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 3.42 | 3.95 | 3.65 | 5.12 | 5.84 | 7.56 | 8.33 | 9.13 |
| EPS · basic | 3.57 | 4.09 | 3.76 | 5.26 | 6.00 | 7.86 | 8.52 | 9.53 |
| Book value / share | 17.95 | 21.96 | 26.12 | 31.60 | 37.96 | 42.56 | 45.68 | 51.98 |
| Tangible BV / share | 16.77 | 20.49 | 24.67 | 29.79 | 36.19 | 42.56 | 45.68 | 51.98 |
| Sales / share | 46.16 | 53.20 | 65.06 | 73.15 | 85.91 | 99.73 | 108.37 | 118.82 |
| Operating CF / share | 4.84 | 4.79 | 6.57 | 5.96 | 9.58 | 9.50 | 10.45 | 11.67 |
| Free cash flow / share | 3.62 | 3.25 | 4.72 | 3.24 | 6.30 | 6.27 | 6.86 | 7.68 |
| Dividends / share | 0.20 | 0.21 | 0.22 | 0.23 | 0.24 | 0.31 | 0.34 | 0.38 |
| Payout ratio | +5.93% | +5.42% | +6.16% | +4.59% | +4.19% | +4.67% | +4.74% | +5.02% |
| Retention ratio | +94.07% | +94.58% | +93.84% | +95.41% | +95.81% | +95.33% | +95.26% | +94.98% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | +15.15% | +23.27% | +14.24% | +18.72% | +15.32% | +10.25% | +9.49% | +15.12% |
| Gross profit · YoY | — | +10.63% | +14.05% | +13.00% | +19.75% | +17.71% | +5.70% | +12.86% | +13.31% |
| Profit | |||||||||
| Operating income · YoY | — | +13.96% | -13.97% | +40.31% | +18.70% | +5.59% | +14.88% | +7.23% | +11.36% |
| EBITDA · YoY | — | +12.32% | -1.98% | +35.47% | +18.69% | +12.13% | +10.15% | +7.23% | +12.94% |
| Net income · YoY | — | +15.43% | -6.80% | +42.30% | +15.44% | +12.83% | +9.54% | +5.32% | +12.64% |
| Operating | |||||||||
| EBIT · YoY | — | +12.52% | -5.76% | +40.42% | +17.55% | +11.52% | +5.99% | +9.10% | +12.33% |
| R&D · YoY | — | — | — | — | — | — | — | — | — |
| Per-share | |||||||||
| EPS · diluted · YoY | — | +15.50% | -7.59% | +40.27% | +14.06% | +29.42% | +10.21% | +9.59% | +15.06% |
| EPS · basic · YoY | — | +14.57% | -8.07% | +39.89% | +14.07% | +31.01% | +8.35% | +11.84% | +15.05% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $1.27B | $1.57B | $1.87B | $1.97B | $4.15B | $3.46B | $3.93B | $4.11B |
| Net debt | $1B | $1.26B | $1.36B | $1.51B | $3.65B | $2.8B | $3.19B | $3.29B |
| Net debt / EBITDA | 3.13 | 3.49 | 3.85 | 3.16 | 6.43 | 4.39 | 4.54 | 4.37 |
| Debt / equity | 1.24 | 1.26 | 1.25 | 1.07 | 1.86 | 1.39 | 1.45 | 1.33 |
| Debt / assets | +44.39% | +45.60% | +44.79% | +42.29% | +76.06% | +53.99% | +56.70% | +53.87% |
| Equity / assets | +35.84% | +36.18% | +35.84% | +39.42% | +40.91% | +38.87% | +39.11% | +40.40% |
| Coverage | ||||||||
| EBITDA / interest expense | 46.84 | 40.35 | 43.68 | 57.75 | 71.10 | 58.98 | 57.21 | 57.60 |
| Operating income / interest | 38.03 | 33.24 | 31.58 | 43.24 | 53.24 | 41.59 | 42.08 | 42.36 |
| Interest expense | $6.85M | $8.93M | $8.09M | $8.29M | $7.99M | $10.8M | $12.26M | $13.06M |
| Liquidity | ||||||||
| Current ratio | 1.22 | 1.34 | 1.42 | 1.56 | 1.42 | — | — | — |
| Quick ratio | 1.16 | 1.27 | 1.38 | 1.48 | 1.35 | — | — | — |
| Cash ratio | 0.50 | 0.54 | 0.69 | 0.62 | 0.56 | — | — | — |
| Working capital | $116.64M | $199.05M | $312.18M | $414.2M | $377.96M | — | — | — |
| Working capital / revenue | +4.44% | +6.58% | +8.37% | +9.72% | +7.47% | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).